Immuron (IMRN) EBT Margin (2016 - 2024)
Immuron's quarterly EBT Margin came in at 63.56% in Q4 2024, up 2445.0% year-on-year from 2.5% in Q1 2024, and up 27.78% quarter-over-quarter from 88.01% in Q4 2023.
Immuron has reported EBT Margin for 9 years, with the latest figure at 63.56% in Q4 2024.
- For the quarter ending Q4 2024, EBT Margin rose 2445.0% year-over-year to 63.56%; the trailing twelve-month figure through Dec 2024 stood at 63.56% (down 6325.0% YoY), and the FY2025 full-year result was 71.58%, up 6991.0% from the prior year.
- EBT Margin for Q4 2024 stood at 63.56%, up from 88.01% in the prior quarter.
- The five-year high for EBT Margin was 0.0% in Q4 2021, with the low at 1493.47% in Q2 2023.
- Average EBT Margin over 5 years is 395.1%, with a median of 213.49% recorded in 2023.
- Year-over-year, EBT Margin surged 38659 bps in 2021 and tumbled 33897 bps in 2022.
- Tracing IMRN's EBT Margin over 5 years: stood at 386.59% in 2020, then jumped by 100 bps to 0.0% in 2021, then sank by 43219211 bps to 338.97% in 2022, then surged by 74 bps to 88.01% in 2023, then gained by 28 bps to 63.56% in 2024.
- The last three EBT Margin figures came in at 63.56% (Q4 2024), 88.01% (Q4 2023), and 1493.47% (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -63.56% |
| Dec 31, 2023 | -88.01% |
| Jun 30, 2023 | -1,493.47% |
| Dec 31, 2022 | -338.97% |
| Dec 31, 2021 | 0.00% |
| Dec 31, 2020 | -386.59% |
| Dec 31, 2019 | -97.73% |
| Dec 31, 2018 | -161.71% |
| Dec 31, 2017 | 535.91% |
| Dec 31, 2016 | 482.10% |
| Jun 30, 2016 | -379.89% |